The U.S. Preventive Services Task Force (USPSTF) has published a draft recommendation statement and draft evidence review that says clinicians should offer “risk-reducing medications” to women at an increased risk for breast cancer.

Healthcare plans and providers are increasingly addressing social determinants of health that can impact patient outcomes and overall costs. Now, California-based Kaiser Permanente is looking at tackling housing insecurity with a $100 million loan fund for affordable housing.

In 2018, the hot M&A market showed no signs of slowing down, with 90 deals announced during the year, according to a recent report from Kaufman Hall.

Walmart and CVS Health will no longer be in the same network for filling prescription drugs after the two companies couldn’t come to a drug pricing agreement, CVS announced.

The longest partial government shutdown in history has paused paychecks for roughly 800,000 workers and stalled the appeal process of a ruling that the Affordable Care Act is unconstitutional.

The National Comprehensive Cancer Network (NCCN) announced Tuesday, Jan. 15, that the NCCN Clinical Practice Guidelines in Oncology were downloaded more than 10 million times in 2018. This is a 26 percent increase compared to 2017.

Rising costs in healthcare was a top issue for voters in the 2018 election, and more emphasis on the industry is likely to come, according to a 2019 outlook from Avalere.

The University of Nebraska–Lincoln was awarded $11 million from the U.S. Department of Defense to develop drug therapies that will treat radiation exposure for the military. If successful, the findings may also be applied to decreasing radiation exposure emitted from medical imaging technologies such as CT or x-rays, according to a recent report by NET News in Nebraska.